Barbara Oil Co’s Ligand Pharmaceuticals LGND Stock Holding History

Barbara Oil Co’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-4,008	Closed	-$285K	–	91
2019 Q2	$285K	Hold	4,008	–	–	0.16%	87
2019 Q1	$314K	Hold	4,008	–	–	0.19%	83
2018 Q4	$339K	Hold	4,008	–	–	0.23%	77
2018 Q3	$686K	Hold	4,008	–	–	0.4%	73
2018 Q2	$518K	Hold	4,008	–	–	0.33%	79
2018 Q1	$413K	Hold	4,008	–	–	0.27%	82
2017 Q4	$342K	Hold	4,008	–	–	0.22%	85
2017 Q3	$340K	Hold	4,008	–	–	0.23%	84
2017 Q2	$304K	Hold	4,008	–	–	0.22%	82
2017 Q1	$265K	Hold	4,008	–	–	0.2%	83
2016 Q4	$254K	Buy	+4,008	New	+$253K	0.2%	78

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

CCMLC

Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SIMG

Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

Barbara Oil Co's LGND Position: Q3 2019 in Review

Barbara Oil Co sold out of Ligand Pharmaceuticals (LGND) in Q3 2019, closing a stake of 4,008 shares — an estimated $285K sold.

Barbara Oil Co first reported a position in LGND in Q4 2016 and held it in 11 quarters. The position peaked at $686K in Q3 2018. 275 funds tracked by Wall St. Rank hold LGND as of Q3 2019.

Barbara Oil Co reported no remaining Ligand Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
Barbara Oil Co sold 4,008 Ligand Pharmaceuticals shares in Q3 2019, an estimated $285K.
Barbara Oil Co first reported a position in Ligand Pharmaceuticals in Q4 2016 and held it in 11 quarters.
Barbara Oil Co's Ligand Pharmaceuticals position peaked at $686K in Q3 2018.
275 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2019.

Based on Barbara Oil Co's 13F filing for Q3 2019, filed 12 Nov 2019.